کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
8824209 1610311 2018 4 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Percutaneous Sclerotherapy for Giant Symptomatic Liver Hemangiomas: A Pilot Study
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی رادیولوژی و تصویربرداری
پیش نمایش صفحه اول مقاله
Percutaneous Sclerotherapy for Giant Symptomatic Liver Hemangiomas: A Pilot Study
چکیده انگلیسی
This single-center prospective trial evaluated the safety and efficacy of percutaneous sclerotherapy for liver hemangiomas in 5 patients (1 man, 4 women; mean age 41.2 y) between 2016 and 2017. All patients were symptomatic (4 abdominal pain; 1 early satiety) and refused surgery. A single session of sclerotherapy with 20 cc mixture of 45 IU. Bleomycin in 10 cc distilled water and 10 cc Lipiodol (Ultra Fluide, Guerbet, France) was performed in all patients, achieving a 45.6%-71.1% lesion volume reduction and a 12.9%-41% reduction in the largest diameter of the lesion. Symptoms subsided in all patients during the 5-month follow-up period. Adverse events included a self-limited intraperitoneal hemorrhage in 1 patient.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Journal of Vascular and Interventional Radiology - Volume 29, Issue 2, February 2018, Pages 233-236
نویسندگان
, , , , , , ,